EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Prevalence of Hepatitis C Infection and Treatment Initiation Following Dried Blood Spot Testing in New South Wales, Australia

Annabelle Stevens iD, Anna Conway, Nigel Carrington, Evan B Cunningham, Alison D Marshall iD, Janaki Amin iD, Phillip Read iD, Tracey Brown iD, Rick Varma iD, Bianca Prain, Philip Cunningham iD, Gregory J Dore iD und 1 weitere

Liver International · 2026-11 · 46 (11)

DOI: 10.1111/liv.70937 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Liver International, online erschienen am 16.10.2026. Verfasst von Annabelle Stevens und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Dried Blood Spot Testing, Hepatitis C. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSW Ministry of Health, NSW Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims To achieve hepatitis C (HCV) elimination by 2030, testing and treatment must reach people most at risk. Dried blood spot (DBS) testing offers an alternative to venepuncture, suitable for community and prison settings. This study evaluated HCV infection prevalence and treatment initiation among people receiving DBS testing in New South Wales (NSW), Australia.

Methods

The NSW DBS Pilot was an observational study of people testing for HCV RNA from DBS samples collected across 36 community sites (including drug treatment clinics and needle and syringe programmes) and 21 prisons. Logistic regression identified factors associated with current HCV infection (detectable HCV RNA) and treatment initiation within 6 months.

Results

Between September 2019 and December 2023, 13 940 participants were tested for HCV (25% female, 33% Aboriginal and/or Torres Strait Islander, 36% injected drugs in the last month). Overall, 11% (1310/13940) had current infection, higher in community (12%) than prison (9%), and declining from 14% in 2019–2021 to 9% in 2022–2023. Among those with current infection, treatment initiation within 6 months was higher in prison settings (64%) compared to community (37%). In community settings, Aboriginal and/or Torres Strait Islander people had lower odds of treatment initiation (aOR 0.69, 95% CI: 0.51–0.92). In prison, treatment declined in 2022–2023 compared with 2019–2021 (aOR 0.64, 95% CI: 0.43–0.94).

Conclusions

The NSW DBS Pilot provided broad access to HCV testing, but treatment initiation remained suboptimal, particularly in community settings. Declining prevalence indicates progress towards elimination; however, further efforts are needed to close remaining gaps along the care cascade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dried Blood Spot TestingHepatitis CHumansNew South WalesFemalePrevalencePilot ProjectsMaleAdultHepacivirusMiddle AgedLogistic ModelsRNA, ViralAustralian Aboriginal and Torres Strait Islander PeoplesPrisonsAntiviral AgentsHealth Services for Prisoners

Stichwörter der Autor:innen

PWIDdried blood spothepatitis Ctestingtreatment

Substanzen

RNA, ViralAntiviral Agents

Autor:innen und Institutionen

  • The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • NSW Health, St Leonards, New South Wales, Australia.
  • Sydney Sexual Health Centre, South Eastern Sydney Local Health District, NSW Health, Sydney, New South Wales, Australia.
  • Centre for Social Research in Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Department of Health Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia.
  • Sexual Health and Blood Borne Virus Services, South Eastern Sydney Local Health District, NSW Health, Sydney, New South Wales, Australia.

ORCID-Profile: Annabelle Stevens, Alison D Marshall, Janaki Amin, Phillip Read, Tracey Brown, Rick Varma, Philip Cunningham, Gregory J Dore, Jason Grebely

Förderung

  • NSW Ministry of Health
  • NSW Health

Zitieren

APA

Stevens, A., Conway, A., Carrington, N., Cunningham, E. B., Marshall, A. D., Amin, J., Read, P., Brown, T., Varma, R., Prain, B., Cunningham, P., Dore, G. J., & Grebely, J. (2026). Prevalence of Hepatitis C Infection and Treatment Initiation Following Dried Blood Spot Testing in New South Wales, Australia. Liver International, 46(11). https://doi.org/10.1111/liv.70937

Vancouver

Stevens A, Conway A, Carrington N, Cunningham EB, Marshall AD, Amin J, et al. Prevalence of Hepatitis C Infection and Treatment Initiation Following Dried Blood Spot Testing in New South Wales, Australia. Liver International. 2026;46(11). doi:10.1111/liv.70937

BibTeX
@article{Stevens2026,
  author = {Stevens, Annabelle and Conway, Anna and Carrington, Nigel and Cunningham, Evan B and Marshall, Alison D and Amin, Janaki and Read, Phillip and Brown, Tracey and Varma, Rick and Prain, Bianca and Cunningham, Philip and Dore, Gregory J and Grebely, Jason},
  title = {Prevalence of Hepatitis C Infection and Treatment Initiation Following Dried Blood Spot Testing in New South Wales, Australia},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {11},
  doi = {10.1111/liv.70937}
}
Kostenlos starten →